Skip to content

Pharmayat

Active Private limited companyfounded 2024active for 2 yearsKrijgskundestraat 19, 1160 AuderghemKBO/BCE: BE 1015.221.301

Lifetime

1 annual account with figures
peak of €35,726 in 2024
€35,726 
peak of €27,855 in 2024
€27,855 
peak of €30,022 in 2024
€30,022 
€30,883 
Board1 name since 2024
1 director
Documentsfilings and deeds
28-07-20253 days before the deadline
2024micro format
Incorporation 21-10Dividend €8331 establishment registeredFirst year with figures

Key points

from the 2024 annual accounts

Turnover

≈ €160,000 estimated

The micro format states no turnover.

Position in the sector

€27,855

Higher net result than 80% of companies in retail trade. The sector median is €4,551, over 25,589 companies.

2025 accounts not filed, 113 days past the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,330 companies had the same profile as Pharmayat has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,330 companies, not a prediction for Pharmayat. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 21-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1015221301
Incorporation Founding capital of €3,000, 100 shares · Founded by (comparant) · appointed as director · published on 21-10-2024 · Gazette deed
First establishment Krijgskundestraat 19, Auderghem
All 4 events

Comparable companies

same main activity, similar in size and age
Company
Pharmayat Auderghem €60,904 €35,726 49.3% -
ELKE SEGERS Grimbergen €63,242 €37,590 73.5% -
Sarah Spruyt Pharma & Care Mechelen €58,307 €38,504 51.7% -
JDS Pharma La Louvière €63,805 €40,475 68.2% -
Charlotte Slabbinck Oudenburg €72,938 €36,678 36.2% -
T.R.F. pharma Fléron €70,151 €42,395 66.4% -
NED PHARMA Mons €74,278 €36,933 31.1% -

These companies have the same main activity as Pharmayat: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €58,300 and €74,300, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 17-10-2024Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.383.237.9361160 Auderghem, since 17-10-2024
Financial year end
31 December
Peppol
Reachable since 17-12-2025
Company details

Annual accounts 2024

€60,904
Filing
Filed on 28-07-2025
Financials

Insights on Pharmayat

The 2024 annual accounts show equity of €30,022 and a net result of €27,855. Its solvency ranks better than 64% of 25,611 sector peers (NACE 47) in financial year 2024.

The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Pharmayat

What is the company number of Pharmayat?
The company number of Pharmayat is 1015.221.301. The VAT number is the same number with BE in front: BE 1015.221.301.
Where is Pharmayat based?
The registered office is at Krijgskundestraat 19, 1160 Auderghem.Company details
What does Pharmayat do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Pharmayat?
Pharmayat is a private limited company (BV).
When was Pharmayat founded?
Pharmayat was founded on 17-10-2024.
Is Pharmayat still active?
Yes, Pharmayat is an active enterprise in the KBO register.
What is the turnover of Pharmayat?
The turnover in financial year 2024 is about €160,000. This figure is estimated from the gross margin of €35,726 and 56 comparable companies (NACE 477). It probably lies between €90,000 and €290,000.Financials
Is Pharmayat profitable?
In financial year 2024, Pharmayat made a profit of €27,855.
Where can I find the annual accounts of Pharmayat?
Pharmayat filed 1 annual account with the National Bank of Belgium, for financial year 2024.
When are the next annual accounts of Pharmayat due?
Pharmayat had to file the annual accounts for financial year 2025 by 31-07-2026. On 21-11-2026 they are not filed yet, 113 days past the deadline.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.